These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9615264

  • 1. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [Abstract] [Full Text] [Related]

  • 2. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
    Rodríguez de la Serna A, Díaz-Rubio M.
    J Rheumatol; 1994 May; 21(5):927-33. PubMed ID: 8064736
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 6. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G.
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [Abstract] [Full Text] [Related]

  • 7. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA.
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M, Perego M, Bargiggia S, Maconi G, Fiocca R, Solcia E, Franceschi M, Cesana B, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213
    [Abstract] [Full Text] [Related]

  • 9. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A, Ozdogan O, Celikel CA, Tozun N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [Abstract] [Full Text] [Related]

  • 10. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.
    Ital J Gastroenterol Hepatol; 1999 Jul; 31(5):378-85. PubMed ID: 10470596
    [Abstract] [Full Text] [Related]

  • 11. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR.
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [Abstract] [Full Text] [Related]

  • 12. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
    Magarò M, Altomonte L, Zoli A, Mirone L, Wielmarin A, Massari M, Destito G, Nazzari M, Psilogenis M.
    Minerva Dietol Gastroenterol; 1989 Sep; 35(1):27-30. PubMed ID: 2725926
    [Abstract] [Full Text] [Related]

  • 13. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL, Codispoti JR, Nelson EB.
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [Abstract] [Full Text] [Related]

  • 14. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
    Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegårdh G, Thorhallsson E, Unge P.
    Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
    Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE.
    Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
    [Abstract] [Full Text] [Related]

  • 17. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
    Simon B, Beckers KH, Biewer W, Bouzo MH, Dammann HG, Gebest HJ, Müller P, Schütz E.
    Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
    [Abstract] [Full Text] [Related]

  • 18. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
    Levine LR, Cloud ML, Enas NH.
    Arch Intern Med; 1993 Nov 08; 153(21):2449-54. PubMed ID: 8215749
    [Abstract] [Full Text] [Related]

  • 19. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN, Smith JL, Lidsky MD, Graham DY.
    Am J Gastroenterol; 1987 Nov 08; 82(11):1153-8. PubMed ID: 3499815
    [Abstract] [Full Text] [Related]

  • 20. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 08; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.